![](/img/cover-not-exists.png)
Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
Moreira, Rodrigo Oliveira, Cobas, Roberta, Lopes Assis Coelho, Raquel C.Volume:
10
Language:
english
Journal:
Diabetology & Metabolic Syndrome
DOI:
10.1186/s13098-018-0327-4
Date:
December, 2018
File:
PDF, 1.00 MB
english, 2018